A phase II study of the combination of bevacizumab with cytotoxic chemotherapy, as first line treatment, in older patients with advanced/metastatic NSCLC (non-squamous)
Pallis, A.G., Vamvakas, L., Karampeazis, A., Polyzos, A., Agelaki, S., Kentepozidis, N., Boukovinas, I., Kotsakis, A., Papadimitraki, E., Koinis, F., Georgoulias, V.Volume:
3
Language:
english
Journal:
Journal of Geriatric Oncology
DOI:
10.1016/j.jgo.2012.10.071
Date:
October, 2012
File:
PDF, 66 KB
english, 2012